Next Article in Journal
Interpreting the Benefit and Risk Data in Between-Drug Comparisons: Illustration of the Challenges Using the Example of Mefenamic Acid versus Ibuprofen
Next Article in Special Issue
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia
Previous Article in Journal
Extracellular Vesicles as Delivery Vehicles for Therapeutic Nucleic Acids in Cancer Gene Therapy: Progress and Challenges
Previous Article in Special Issue
Optimization of a Novel Mandelamide-Derived Pyrrolopyrimidine Series of PERK Inhibitors
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 14
Issue 10
10.3390/pharmaceutics14102238
Version Notes
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

Printed Edition

A printed edition of this Special Issue is available at MDPI Books....
share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Article

Article Versions Notes

Pharmaceutics 2022, 14(10), 2238; https://doi.org/10.3390/pharmaceutics14102238
Action Date Notes Link
article xml file uploaded 20 October 2022 08:51 CEST Original file -
article xml uploaded. 20 October 2022 08:51 CEST Update https://www.mdpi.com/1999-4923/14/10/2238/xml
article pdf uploaded. 20 October 2022 08:51 CEST Version of Record https://www.mdpi.com/1999-4923/14/10/2238/pdf
article supplementary file uploaded. 20 October 2022 08:51 CEST - https://www.mdpi.com/1999-4923/14/10/2238#supplementary
article html file updated 20 October 2022 08:53 CEST Original file -
article html file updated 1 March 2023 23:05 CET Update https://www.mdpi.com/1999-4923/14/10/2238/html
Back to TopTop